Bioenergetics, mitochondrial dysfunction, and oxidative stress in the pathophysiology of septic encephalopathy
Alzheimers disease: genes, proteins, and therapy
This article examines the relationship between GLP-1 therapy and heart rate, explores the underlying mechanisms, reviews cardiovascular safety data, and provides guidance on when to seek medical advice
The researchers noted that the use of GLP-1 drugs in people with schizophrenia spectrum conditions helped with comorbid diabetes and obesity
[14] [13] These mechanisms contribute to improved glycaemic control and weight loss, but they can also lead to reduced caloric intake, changes in eating patterns, and occasionally low blood glucose levels (hypoglycaemia), all of which may contribute to feelings of tiredness